PubRank

David R Boulware

Author PubWeight™ 58.06‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings. Clin Infect Dis 2010 4.08
2 Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. Clin Infect Dis 2008 3.91
3 Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis 2010 2.86
4 Travel medicine considerations for North American immigrants visiting friends and relatives. JAMA 2004 2.70
5 Diagnostic performance of rapid diagnostic tests versus blood smears for malaria in US clinical practice. Clin Infect Dis 2009 1.91
6 Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care. J Acquir Immune Defic Syndr 2012 1.85
7 Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PLoS One 2013 1.84
8 Cost-effective diagnostic checklists for meningitis in resource-limited settings. J Acquir Immune Defic Syndr 2013 1.71
9 Strongyloides hyperinfection presenting as acute respiratory failure and gram-negative sepsis. Chest 2005 1.57
10 Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast. Emerg Infect Dis 2014 1.55
11 Biomarkers of HIV Immune Reconstitution Inflammatory Syndrome. Biomark Med 2008 1.55
12 Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis. PLoS Med 2012 1.53
13 Reduction of immune activation with chloroquine therapy during chronic HIV infection. J Virol 2010 1.32
14 Cryptococcal genotype influences immunologic response and human clinical outcome after meningitis. MBio 2012 1.28
15 Central nervous system immune reconstitution inflammatory syndrome. Curr Infect Dis Rep 2013 1.21
16 Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid. Clin Infect Dis 2013 1.19
17 Long term 5-year survival of persons with cryptococcal meningitis or asymptomatic subclinical antigenemia in Uganda. PLoS One 2012 1.16
18 The Cryptococcus neoformans transcriptome at the site of human meningitis. MBio 2014 1.11
19 Cryptococcus neoformans ex vivo capsule size is associated with intracranial pressure and host immune response in HIV-associated cryptococcal meningitis. J Infect Dis 2013 1.11
20 Acute heart failure from lyme carditis. Circ Heart Fail 2012 1.09
21 Methods of rapid diagnosis for the etiology of meningitis in adults. Biomark Med 2014 1.03
22 Comparative genome sequencing of an isogenic pair of USA800 clinical methicillin-resistant Staphylococcus aureus isolates obtained before and after daptomycin treatment failure. Antimicrob Agents Chemother 2011 1.01
23 Strategies to reduce mortality and morbidity due to AIDS-related cryptococcal meningitis in Latin America. Braz J Infect Dis 2013 1.00
24 Impact of global health residency training on medical knowledge of immigrant health. Am J Trop Med Hyg 2011 0.98
25 The clinical pattern, prevalence, and factors associated with immune reconstitution inflammatory syndrome in Ugandan children. AIDS 2010 0.96
26 Comparison of cryptococcal antigenemia between antiretroviral naïve and antiretroviral experienced HIV positive patients at two hospitals in Ethiopia. PLoS One 2013 0.95
27 Reconsidering cryptococcal antigen screening in the U.S. among persons with CD4 <100 cells/mcL. Clin Infect Dis 2012 0.95
28 Significantly improved analytical sensitivity of lateral flow immunoassays by using thermal contrast. Angew Chem Int Ed Engl 2012 0.93
29 Biomarkers of inflammation and coagulation are associated with mortality and hepatitis flares in persons coinfected with HIV and hepatitis viruses. J Infect Dis 2013 0.93
30 Financial implications of refugee malaria: the impact of pre-departure presumptive treatment with anti-malarial drugs. Am J Trop Med Hyg 2007 0.92
31 Cryptococcus-Related Immune Reconstitution Inflammatory Syndrome(IRIS): Pathogenesis and Its Clinical Implications. Curr Fungal Infect Rep 2011 0.90
32 Role of quantitative CSF microscopy to predict culture status and outcome in HIV-associated cryptococcal meningitis in a Brazilian cohort. Diagn Microbiol Infect Dis 2012 0.83
33 Accuracy of pima point-of-care CD4 analyzer in routine use in public health clinics in Uganda. J Acquir Immune Defic Syndr 2013 0.80
34 AIDS-related mycoses: the way forward. Trends Microbiol 2014 0.80
35 A case for treating high hepatitis B DNA levels before starting HIV therapy. AIDS 2006 0.79
36 Nosocomial drug-resistant bacteremia in 2 cohorts with cryptococcal meningitis, Africa. Emerg Infect Dis 2014 0.79
37 The immunopathogenesis of cryptococcal immune reconstitution inflammatory syndrome: understanding a conundrum. Curr Opin Infect Dis 2016 0.78
38 Thermal Contrast Amplification Reader Yielding 8-Fold Analytical Improvement for Disease Detection with Lateral Flow Assays. Anal Chem 2016 0.77
39 Safety, censoring, and intent-to-treat analysis: dangers to generalizability. Clin Infect Dis 2010 0.76
40 The CSF immune response in HIV-1-associated cryptococcal meningitis: macrophage activation, correlates of disease severity and effect of antiretroviral therapy. J Acquir Immune Defic Syndr 2017 0.75
41 Brief Report: Effects of Tenofovir and Amphotericin B Deoxycholate Coadministration on Kidney Function in Patients Treated for Cryptococcal Meningitis. J Acquir Immune Defic Syndr 2016 0.75
42 Migrants, detainees, and misconceptions. Lancet 2009 0.75
43 Antiretroviral therapy after cryptococcal meningitis. N Engl J Med 2014 0.75
44 Implementation and Operational Research: Impact of Nurse-Targeted Care on HIV Outcomes Among Immunocompromised Persons: A Before-After Study in Uganda. J Acquir Immune Defic Syndr 2016 0.75
45 The trials of the returning traveler: ciprofloxacin failure in enteric fever. Minn Med 2008 0.75
46 Brief Report: Virologic Monitoring Can Be a Cost-Effective Strategy to Diagnose Treatment Failure on First-Line ART. J Acquir Immune Defic Syndr 2016 0.75
47 Hypereosinophilic syndrome and mepolizumab. N Engl J Med 2008 0.75
48 The role of nanoparticle design in determining analytical performance of lateral flow immunoassays. Nano Lett 2017 0.75